1. Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia
   Ramachandran Krishna Chandran et al, 2019, Frontiers in Oncology CrossRef
2. CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation
   ZHENGHUAN FANG et al, 2015, International Journal of Oncology CrossRef
3. High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma
   Abdulraheem Alshareef et al, 2017, Scientific Reports CrossRef
4. Isodicentric Philadelphia chromosome: an uncommon chromosomal abnormality in the chronic phase of chronic myeloid leukemia (CML)
   Eric Loo et al, 2016, Clinical Case Reports CrossRef
5. Novel Molecular Challenges in Targeting Anaplastic Lymphoma Kinase in ALK-Expressing Human Cancers
   Abdulraheem Alshareef, 2017, Cancers CrossRef
6. Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors
   Konstantin Byrgazov et al, 2016, Oncotarget CrossRef